NEWSROOM
Latest Learnings
Get the latest insights, news, and expert articles from Viromme.
LAtest News
Jan 26, 2025
Pre-Print
Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry
Jan 26, 2025
Pre-Print
Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry
Jan 26, 2025
Pre-Print
Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry
Jan 21, 2025
Announcement
Model Medicines, Icahn School of Medicine at Mount Sinai, and University of California, San Diego Researchers Publish Groundbreaking Preprint on MDL-001, A Broad-Spectrum Antiviral
Jan 21, 2025
Announcement
Model Medicines, Icahn School of Medicine at Mount Sinai, and University of California, San Diego Researchers Publish Groundbreaking Preprint on MDL-001, A Broad-Spectrum Antiviral
Jan 21, 2025
Announcement
Model Medicines, Icahn School of Medicine at Mount Sinai, and University of California, San Diego Researchers Publish Groundbreaking Preprint on MDL-001, A Broad-Spectrum Antiviral
Jan 14, 2025
Pre-Print
MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases
Jan 14, 2025
Pre-Print
MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases
Jan 14, 2025
Pre-Print
MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases
Apr 8, 2024
Pre-Print
RdRp Thumb-1, A Universal RNA Antiviral Target, and MDL-001, a Potent Inhibitor
Apr 8, 2024
Pre-Print
RdRp Thumb-1, A Universal RNA Antiviral Target, and MDL-001, a Potent Inhibitor
Apr 8, 2024
Pre-Print